Media Releases

2022

15/08/2022

Proteomics International raises $8m in highly successful Placement

09/08/2022

Proteomics International signs binding letter of intent with Sonic Healthcare USA to take PromarkerD into the US market

02/08/2022

American doctors give tick to Proteomics kidney test – The West Australian

02/08/2022

Clinical Utility Study demonstrates PromarkerD test benefits

01/08/2022

Potential breakthrough blood test able to detect people with endometriosis

01/08/2022

Boost for Proteomics in fight against painful disorder – The West Australian

25/07/2022

European PromarkerD patents expanded beyond diabetes

30/06/2022

Promarker™ pipeline – Endometriosis update Diagnostic readout positive: Study expanded

28/06/2022

QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International – Precision Oncology News

21/06/2022

Proteomics International (ASX:PIQ) secures licence for oesophageal cancer biomarkers – The Market Herald

21/06/2022

Proteomics International secures exclusive licence to oesophageal cancer biomarkers

16/06/2022

Pilot test kit takes Proteomics step closer to sales – The West Australian

16/06/2022

Proteomics International Laboratories (ASX:PIQ) completes PromarkerD manufacturing tech transfer – The Market Herald

16/06/2022

PromarkerD manufacturing tech-transfer completed – Successful production of components for over 50,000 tests

06/06/2022

Study boosts diagnostic potential for Proteomics – The West Australian

Newsroom

News Archive

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Subscribe

  • This field is for validation purposes and should be left unchanged.
Menu